Similar Posts
Zacks Research Weighs in on Editas Medicine FY2028 Earnings
Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Analysts at Zacks Research issued their FY2028 earnings estimates for Editas Medicine in a note issued to investors on Monday, March 23rd. Zacks Research analyst Team expects that the company will post earnings of ($1.34) per share for the year. Th Source link
Weekly Initial Unemployment Claims Decrease to 213,000
by Calculated Risk on 2/13/2025 08:30:00 AM The DOL reported: In the week ending February 8, the advance figure for seasonally adjusted initial claims was 213,000, a decrease of 7,000 from the previous week’s revised level. The previous week’s level was revised up by 1,000 from 219,000 to 220,000. The 4-week moving average was 216,000,…
Is Stop Loss is a Scam: The Hidden Truth Behind Retail Trading Losses
Introduction: The Great Stop Loss Deception If you’ve been trading for a while, you’ve probably been told that setting a Stop Loss (SL) is essential to protect your capital. Brokers, trading courses, and even some “successful” traders on YouTube swear by it. But what if I told you that Stop Loss is a tool designed to…
TPSL Bounding Box DEMO
TPSL Bounding Box DEMO Source link
Retail Sales Increased 1.4% in March
by Calculated Risk on 4/16/2025 08:30:00 AM On a monthly basis, retail sales increased 1.4% from February to March (seasonally adjusted), and sales were up 4.6 percent from March 2024. From the Census Bureau report: Advance estimates of U.S. retail and food services sales for March 2025, adjusted for seasonal variation and holiday and trading-day…
AVUV: Time To Rebalance After Recent Dip (NYSEARCA:AVUV)
AVUV: Time To Rebalance After Recent Dip Source link
